Despite a recent sell-off, DraftKings may be quietly building its next major growth engine through nationwide expansion into prediction markets.

In the assessment of 12-month price targets, analysts unveil insights for Caris Life Sciences, presenting an average target of $30.0, a high estimate of $38.00, and a low estimate of $26.00. This ...

According to Mercer's 2024 AI in Investment Management global manager survey, 91% of asset managers either currently use AI (54%) or plan to use it within their investment strategy or asset-class ...

While the after-hours in the wake of Nvidia’s latest earnings report failed to be genuinely decisive, DeepSeek took a very optimistic stance.

Accenture's robust demand, record backlog, and margin expansion support a continued positive outlook. Read why ACN stock is a ...

I met a man at a conference three years ago who seemed completely unremarkable. He wore normal clothes. Drove a normal car. Made small talk about normal things. Nothing about him suggested he was ...

Right now, the company trades at a forward price-to-earnings ratio (P/E) of about 12. That's roughly half the forward P/E of ...

McKesson Corporation is rated a Hold due to low debt burden and faces risks from regulatory and margin pressures. Learn more ...

Artificial intelligence is reshaping how investors think about growth, competitive advantage, and long-term value. For years, Alphabet has been a ...

New board nominees Glenda Dorchak, Eliot Pence, Michelle Reynolds, and The Hon. Heidi Shyu, in addition to Christian Weedbrook and Bill Fradin, ...

Listen in as Motley Fool co-founder Tom Gardner and Chief Investment Officer Andy Cross talk about stocks!

The AI Stock Analysis market is booming, brimming with innovative solutions that aim to transform the way investors operate ...